Finally, the “HCV-HCC-specific” signature included: ABL2, ACSL4, AKR1B10, CCT3, CDKN2A, EIF3H, FLVCR1, GBAP1, GPC3, HKDC1, HNRNPU, IGF2BP3, LOC344887, MRPL9, MTR, PRCC, PRKDC, PSPH, RAD21, SMYD3, SQSTM1, SRXN1, TBC1D31, TBCE, TERF1, TMEM106C, TRIM31, TXNRD1, UBR5, VASH2, ZNF623 (Fig. 3C). This evidence concerns the gene MRPL9 and hepatocellular carcinoma.